Key Metrics
8.5
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
61
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
0.87
5-Year SI
5-year SI
- N/A 2-year SI
- 0.86 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q1
Oncology
SJR
- Q1 Oncology
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
1.35
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
5 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Topics Covered
- Cancer
- Lung cancer
- Drug discovery
- Progression-free survival
- Breast cancer
- Immunotherapy
- Immune checkpoint inhibitors
- Confidence interval
- Overall survival
- Colorectal cancer
- Extensive-stage small cell lung cancer
- Epidermal growth factor receptor
- Neuroendocrine tumors
- Hepatocellular carcinoma
- Germline
- Ketogenic diet
- Surgical resection
- Clinical trial
- Systematic review
- Objective response
Journal Specifications
| Overview | |
| Publisher | SAGE PUBLICATIONS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2300 |
| Publication Time | 15 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2009 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 15 |
| Article Processing Charges | USD 2300 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
Planning to publish in Therapeutic Advances in Medical Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Multivariate prognostic index and triplet regimen efficacy predictive index in locally advanced and metastatic gastric cancer: pooled analysis from three clinical trials using individual patient data.
- 1 Jan 24
- Therapeutic advances in medical oncology
-
Full paper
Delays in diagnosis and surgery of sarcoma patients during the COVID-19 outbreak in Spain.
- 1 Jan 24
- Therapeutic advances in medical oncology
-
Full paper
Phosphaturic mesenchymal tumor with de novo liver metastases: a case report and literature review.
- 1 Jan 24
- Therapeutic advances in medical oncology
-
Full paper
Major adverse cardiovascular events in advanced-stage lung cancer: a multicenter cohort study.
- 1 Jan 24
- Therapeutic advances in medical oncology
-
Full paper
Prospective observational study to explore genes and proteins predicting efficacy and safety of brigatinib for ALK-gene rearranged non-small-cell lung cancer: study protocol for ABRAID study (WJOG11919L).
- 1 Jan 24
- Therapeutic advances in medical oncology
-
Full paper
Clinical and molecular characteristics of RNF43 mutations as promising prognostic biomarkers in colorectal cancer.
- 1 Jan 24
- Therapeutic advances in medical oncology
Scite analysis
Powered by scite_
1.3k articles received 22k citations see all
- 566 Supporting
- 20,921 Mentioning
- 85 Contrasting
Editorial notices
- 8 Retractions
- 0 Withdrawals
- 29 Corrections
- 24 Errata
- 0 Expression of Concern
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
5%
4 to 6 months
55%
7 to 9 months
34%
Above 9 months
6%
Did you find this useful?
Thank you for your feedback.
FAQs
How long has Therapeutic Advances in Medical Oncology been actively publishing?
Therapeutic Advances in Medical Oncology has been in operation since 2009 till date.
What is the publishing frequency of Therapeutic Advances in Medical Oncology ?
Therapeutic Advances in Medical Oncology published with a Continuous publication frequency.
How many articles did Therapeutic Advances in Medical Oncology publish last years ?
In 2023, Therapeutic Advances in Medical Oncology published 166 articles.
What is the eISSN & pISSN for Therapeutic Advances in Medical Oncology ?
For Therapeutic Advances in Medical Oncology,eISSN is 1758-8359 and pISSN is1758-8340.
What is Citescore for Therapeutic Advances in Medical Oncology ?
Citescore for Therapeutic Advances in Medical Oncology is 8.5.
What is H index for Therapeutic Advances in Medical Oncology ?
H index for Therapeutic Advances in Medical Oncology is 61.
What is SNIP score for Therapeutic Advances in Medical Oncology ?
SNIP score for Therapeutic Advances in Medical Oncology is 1.35.
What is the SJR for Therapeutic Advances in Medical Oncology ?
SJR for Therapeutic Advances in Medical Oncology is Q1.
Who is the publisher of Therapeutic Advances in Medical Oncology ?
SAGE PUBLICATIONS LTD is the publisher of Therapeutic Advances in Medical Oncology.